Sanofi trial failure ends development of breast cancer treatment amcenestrant

(marketscreener.com) -French healthcare company Sanofi said it would stop further work on amcenestrant, once seen to have large potential against breast cancer, after a second trial failure dealt a major blow to its drug development prospects.https://www.marketscreener.com/news/latest/Sanofi-trial-failure-ends-development-of-breast-cancer-treatment-amcenestrant--41336978/?utm_medium=RSS&utm_content=20220817